Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lidocaine Infusion With Enhanced Recovery Program for Pancreatic Cancer Surgery: Effect on Pain and Patient Immunity

NCT05470166 is registered in ClinicalTrials.gov with Alexandria University as lead sponsor.

NCT NCT05470166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05470166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lidocaine Infusion With Enhanced Recovery Program for Pancreatic Cancer Surgery: Effect on Pain and Patient Immunity
Lead sponsor
Alexandria University
Phase
Not applicable
Overall status
Completed
Start date
April 20, 2022
Completion date
April 1, 2024
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of pancreas, eras, lidocaine, natural killer cell cytokine production